1. Home
  2. Press release
Apr 11, 2016 13:45 JST

Source: Showa Denko K.K.

Showa Denko Allies with Azelis in Cosmetic Materials

TOKYO, Apr 11, 2016 - (JCN Newswire) - Showa Denko ("SDK"; TSE:4004) has agreed with Azelis that the two parties form a business alliance to market SDK's cosmetic raw materials in Europe.

Azelis is a leading global speciality chemicals distributor with businesses in 40 countries, providing a diverse range of products and innovative services to more than 27,000 customers. In the field of personal care products including cosmetic materials, its application research laboratory has developed more than 3,000 formulas. Through its suggestions of products that meets variety of uses and intensive technical support, Azelis has been expanding its scale of business. This time, SDK and Azelis concluded an exclusive distributorship agreement to enable Azelis to market SDK's vitamin derivatives (APM, APPRECIER(TM), TPNa(TM)), a slimming agent (Hi-Carnitine), and hair care products (DL-Cysteine, SPIERA(TM)) in Europe. Azelis starts its marketing activities for SDK's products form this month.

Whether a cosmetic material can demonstrate enough effectiveness depends on development of formulas. Moreover, the needs of customers to cosmetics greatly vary by region. SDK's cosmetic raw materials have already been rated high by customers inside and outside Japan. SDK expects that the sales of its cosmetic raw materials in Europe will significantly increase, taking advantage of Azelis' sales network in European countries and expertise and know-how about development of formulas that meet European consumers' needs.

Under its ongoing medium-term consolidated business plan "Project 2020+," SDK aims to expand its individualized businesses by accelerating development of overseas markets. SDK will further improve its sales network for cosmetic raw materials, thereby meeting customers' expectations at home and abroad.

Outline of Azelis Group

Head office: The Grand Duchy of Luxembourg
Establishment: 2001
Scope of business: Sales of speciality chemicals and innovative ingredients
Group CEO: Hans-Joachim Muller

The products subject to the exclusive distributorship agreement

Skin Care Lines: Vitamins
1) APM
INCI NAME: MAGNESIUM ASCORBYL PHOSPHATE
APM is a stable and active provitamin C.
- Stable against oxidation
- Easy for formulation
- High skin bio-availability of vitamin C

2) APPRECIER(TM)(APPS)
INCI NAME: TRISODIUM ASCORBYL PALMITATE PHOSPHATE
APPS is a newly designed amphiphilic derivative of ascorbyl 2-phosphate (AP).
- Moderate hydrophobicity
- High transdermal permeation
- Effective delivery of vitamin C

3) TPNa(TM)
INCI NAME: SODIUM TOCOPHERYL PHOSPHATE
Vitamin E derivative, TPNa(TM), is designed as water-soluble powder which is quite stable but is readily converted to the active a -tocopherol in the skin.
- Water-soluble powder
- Easy for formulation
- High anti-oxidant effects

Skin Care Lines: Slimming
4) Hi-Carnitine (HLC)
INCI NAME: PALMITOYL CARNITINE
L-carnitine is well-known supplement for weight control by combustion of accumulated fat. Our L-carnitine derivative, HLC, has advantage not only on slimming but on various skin troubles.
- Satisfactory transdermal bioavailability
- Efficient slimming effect
- Skin care efficacies on anti-age, hydration, and hair growth

Hair Care Products
5) DL-Cysteine, DL-Cysteine HCl
INCI NAME: CYSTEINE, CYSTEINE HCl
General cysteine-type permanent wave agents were difficult to use because of low solubility, segmentation and cloudy appearance in water. The improved DL-Cysteine agents have;
- No recrystallization
- High solubility in water
- High perming performance
- No harm on hair and hands

6) SPIERA(TM)
INCI NAME: BUTYROLACTONETHIOL
SPIERA(TM) is perm and hair relaxer agent with mild acidity and superior performance compared with current alkaline processing treatments.
- No damage on hair
- No chemical odor
- No coloring retardation

Contact:
Showa Denko
Public Relations Office
Phone: 81-3-5470-3235
Source: Showa Denko K.K.
Sectors: Chemicals, Spec.Chem, Speciality Chemicals

Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.

Related Press Release

Showa Denko Launches Mass Production of 6-inch SiC Single Crystal Wafers
March 28 2022 11:00 JST
 
SDK Corrects Segment Information in 2021 Consolidated Financial Statements
March 11 2022 14:00 JST
 
Showa Denko Group Starts to Consider Transformation into Holding Company Structure
March 09 2022 14:00 JST
 
Showa Denko Decides Firm Name of the Newly Integrated Company
March 09 2022 14:00 JST
 
SDK Announces 2021 Consolidated Financial Results
February 14 2022 13:00 JST
 
SDK to Revise Amount of Director Compensation (in Money) Following Revision of Director Compensation Scheme and to Partially Revise Performance-Linked Stock Compensation Scheme
February 14 2022 13:00 JST
 
Showa Denko Accelerates Search for Optimal Formulation of Semiconductor Materials with Quantum Computing Technology
February 10 2022 12:00 JST
 
Showa Denko Revises Forecast of Consolidated Performance
February 09 2022 15:00 JST
 
New Year Message from Hidehito Takahashi, Showa Denko President and CEO
January 04 2022 13:00 JST
 
Showa Denko Develops HD Media for MAS-MAMR Technology
December 10 2021 12:30 JST
 
More Press release >>

Latest Press Release


Honda Unveils Demonstration Production Line for All-Solid-State Batteries Located in Sakura City, Tochigi Prefecture, Japan
Nov 21, 2024 15:35 JST

Deadline to Lead in Securities Fraud Lawsuit Against Humacyte, Inc. (HUMA) is January 17, 2025 - Contact Kaplan Fox & Kilsheimer LLP
Nov 21, 2024 09:00 JST

ALL Study Groups Using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria's 12-Week GLP-1, Diabetes Animal Study
Nov 20, 2024 23:05 JST

Start of Demonstration Test of Two-Phase Direct-to-Chip Cooling in the Air-Cooled Data Center
Nov 20, 2024 15:30 JST

Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan
Nov 20, 2024 11:51 JST

Anticancer Agent "TASFYGO Tablets 35mg" (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements
Nov 20, 2024 10:24 JST

Kingsoft Announces 2024 Third Quarter Results
Nov 19, 2024 18:54 JST

NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System
Nov 19, 2024 15:30 JST

Supercomputer Fugaku retains first place worldwide in HPCG and Graph500 rankings
Nov 19, 2024 09:02 JST

CleverTap Recognized as a Strong Performer in Cross-Channel Marketing Hubs, Q4 2024 Report
Nov 18, 2024 23:30 JST

World's First Successful Trial of Quantum Tokens Created Using Quantum Technology
Nov 18, 2024 17:29 JST

Fujitsu and SAP Fioneer enter partnership to accelerate digital transformation in the insurance industry and deliver services that contribute to customers' sustainable business
Nov 18, 2024 12:31 JST

Expanding Possibilities with the Liquid Hydrogen-Powered GR Corolla in the Season Final Round
Nov 18, 2024 09:25 JST

COP29: Indonesian Special Envoy Hashim Djojohadikusumo Announces EUR 1,2 Billion Green Funding
Nov 16, 2024 18:00 JST

Mitsubishi Shipbuilding Holds Christening and Launch Ceremony of LNG-Powered Roll-on/Roll-off Ship TRANS HARMONY EMERALD in Shimonoseki
Nov 15, 2024 18:58 JST

Nationwide TV Commercial Launched in Japan to Raise Awareness About MCI (Mild Cognitive Impairment)
Nov 15, 2024 17:33 JST

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease
Nov 15, 2024 14:31 JST

Resorttrust Group and Mitsubishi Corporation Launch Joint Study in Medical Tourism
Nov 15, 2024 12:32 JST

Fujitsu collaborates with global suppliers in decarbonization initiative to exchange product-level primary data on CO2 emissions
Nov 15, 2024 10:13 JST

TANAKA Successfully Develops the World's First[1] Manufacturing Technology for Platinum Materials with Nano-Sized Crystal Grains
Nov 15, 2024 04:00 JST
 More Latest Release >>